Jump to navigation
Donate
FDA approves Opill as the first OTC birth control pill in the United States!
Misoprostol-only resource hub: Highlighting its safety & effectiveness
Announcing new partnership with AMAZE.org in the Africa region
Announcing the launch of Ibis's Africa Region Strategy for 2022-2025
Celebrating 20 years of impact: A visual chronicle of Ibis's history
A just, inclusive world where we all exercise our human right to a pleasurable, safe, and healthy sexual and reproductive life.
#IbisDrivesChange
Client-reported quality of facility-managed medication abortion compared with pharmacy-sourced self-managed abortion in Bangladesh
Quality of care from the perspective of people obtaining abortion: a qualitative study in four countries
Emotional, informational, and decision-making support needs among people seeking abortion in the US: perspectives from All-Options Talkline callers
Dr. Caitlin Gerdts receives Society of Family Planning’s 2023 lifetime achievement award
FDA approves the first-ever over-the-counter birth control pill in the United States
Biden issues executive order on improving access to contraception
